Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,329 | 69,547 | 34,273 | 15,752 | 10,686 |
| Marketable Securities | N/A | N/A | N/A | 54,602 | 54,784 |
| Receivables | 77 | 4,416 | 487 | N/A | N/A |
| Inventories | 2,463 | 1,022 | N/A | N/A | N/A |
| TOTAL | $51,179 | $77,530 | $39,115 | $74,328 | $67,650 |
| Non-Current Assets | |||||
| PPE Net | 589 | 1,052 | 3,887 | 3,894 | 3,102 |
| Other Non-Current Assets | 2,366 | 3,015 | 1,719 | 1,903 | 3,402 |
| TOTAL | $2,955 | $4,067 | $5,606 | $5,797 | $6,504 |
| Total Assets | $54,134 | $81,597 | $44,721 | $80,125 | $74,154 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,938 | N/A | N/A | 41,693 | 35,315 |
| Accounts payable and accrued liabilities | 1,896 | 2,464 | 507 | 845 | 348 |
| Accrued Expenses | 13,511 | 13,860 | 2,655 | 3,266 | 3,114 |
| TOTAL | $29,012 | $17,024 | $3,459 | $46,055 | $39,475 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,983 | 42,874 | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | N/A | 500 |
| Other Non-Current Liabilities | 3,231 | 910 | 1,229 | 1,449 | 1,693 |
| TOTAL | $34,982 | $44,810 | $1,229 | $1,465 | $1,693 |
| Total Liabilities | $63,994 | $61,834 | $4,688 | $47,520 | $41,168 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 9,178 | 4,242 | 4,185 | 2,752 | 2,544 |
| Common Shares | 9 | 4 | 4 | 3 | 3 |
| Retained earnings | -307,027 | -230,448 | -163,453 | -138,966 | -103,886 |
| Other shareholders' equity | 0 | 0 | 0 | -29 | 1 |
| TOTAL | $-9,860 | $19,763 | $40,033 | $32,605 | $32,986 |
| Total Liabilities And Equity | $54,134 | $81,597 | $44,721 | $80,125 | $74,154 |